$39.84
1.493.89%
At close: -
$39.84
0.000.00%
After Hours: Dec 20, 5:13 PM EDT
Comments
Loading...
Aligos Therapeutics (NASDAQ:ALGS) Stock, Earnings Estimates, EPS, And Revenue
Aligos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS Estimate
$-3.670
Quarterly Revenue Estimate
$433.3K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$6M
Analyze the earnings history of Aligos Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Aligos Therapeutics (ALGS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $-3.07 | $-2.16 | -42.1 % |
| Jun 2024 | 2024-08-06 | $0.75 | $-4.00 | 118.8 % |
| Mar 2024 | 2024-05-07 | $-5.50 | $-4.75 | -15.8 % |
| Dec 2023 | 2024-03-12 | $-5.50 | $-6.75 | 18.5 % |
Aligos Therapeutics (ALGS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $1.27M | $330.00K | 284.6 % |
| Dec 2023 | 2024-03-12 | $2.01M | $1.60M | 25.6 % |
| Sep 2023 | 2023-11-02 | $2.15M | $2.50M | -13.8 % |
| Dec 2022 | 2023-03-09 | $3.54M | $1.72M | 105.6 % |
FAQ
When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?
Aligos Therapeutics (ALGS) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Aligos Therapeutics (NASDAQ:ALGS)?
The Actual EPS was $-3.07, which missed the estimate of $-2.16.
What were Aligos Therapeutics’s (NASDAQ:ALGS) revenues?
The Actual Revenue was $1.3M, which beat the estimate of $330K.
Browse earnings estimates, EPS, and revenue on all stocks.